Medicine
Citric Buffered Normal Saline 166 mg/270 mL injection
Citric Buffered Normal Saline 166 mg/270 mL injection is a prescription medicine containing Anhydrous citric acid for intravenous use, marketed by Meitheal Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in a refrigerator. Do not freeze. The diluent bags should be stored in…
Key facts
- Active ingredient (INN)
- Anhydrous citric acid
- Brand
- Citric Buffered Normal Saline
- Strength
- 166 mg/270 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 6 bags of 270 mL
- Marketing authorisation holder
- Meitheal Pharmaceuticals
- Manufacturer
- Meitheal Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store in a refrigerator. Do not freeze. The diluent bags should be stored in barrier overwrap at 2°C to 25°C (36°F to 77°F) until ready to use.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A09AB04 Anhydrous citric acid
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 September 2019
- Identifiers
- RxCUI 2198948, 2198953, 2198961 +3DailyMed set ID eb972ea8-7502-422e-84bb-66cb8e93ca06NDC 71288-040Application NDA211673
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 bag in 1 carton / 270 mL in 1 bag | 71288-040-65 | Meitheal Pharmaceuticals | 9 September 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Anhydrous citric acid is an anti-coagulant indicated for the treatment of adults with community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Anhydrous citric acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Anhydrous citric acidFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xenleta prescribing information (Meitheal Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Citric Buffered Normal Saline 166 mg/270 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.